SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci. Read more about SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci.
Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations. Read more about Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations.
Protein-adaptive differential scanning fluorimetry using conformationally responsive dyes. Read more about Protein-adaptive differential scanning fluorimetry using conformationally responsive dyes.
Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling. Read more about Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.
Design of a mucin-selective protease for targeted degradation of cancer-associated mucins. Read more about Design of a mucin-selective protease for targeted degradation of cancer-associated mucins.
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Read more about Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
Microfluidics-free single-cell genomics with templated emulsification. Read more about Microfluidics-free single-cell genomics with templated emulsification.
High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform. Read more about High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. Read more about Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Read more about Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
